GUIDELINES FOR THE RISK ASSESSMENT OF NEW SYNTHETIC DRUGS

Documents similaires

• REPORT ON THE RISK ASSESSMENT OF MBDB IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS. GUIDELINES FOR THE RISK ASSESSMENT OF NEW SYNTHETIC DRUGS
  Publié: (2000)
• REPORT ON THE RISK ASSESSMENT OF GHB IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS
  Publié: (2002)
• REPORT ON THE RISK ASSESSMENT OF PMMA IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS
  Publié: (2003)
• EARLY-WARNING SYSTEM ON NEW SYNTHETIC DRUGS. GUIDANCE ON IMPLEMENTATION
  Publié: (2005)
• REPORT ON THE RISK ASSESSMENT OF TMA-2 IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS
  Publié: (2004)